(Q51573986)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9284856%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Effects of troglitazone on insulin action and cardiovascular risk factors in patients with non-insulin-dependent diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9284856%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9284856%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Giuseppe Seghieri

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9284856%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Roberto Anichini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9284856%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

8

Ferrannini E

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9284856%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Sironi AM

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9284856%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Vichi S

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9284856%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Pecori N

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9284856%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Foot E

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9284856%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 August 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9284856%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9284856%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9284856%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9284856%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

194-202

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9284856%20AND%20SRC:MED&resulttype=core&format=json

Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990068-0

Pathogenesis of NIDDM. A balanced overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990068-0

Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990068-0

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990068-0

Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990068-0

In vitro studies on the action of CS-045, a new antidiabetic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990068-0

Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990068-0

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990068-0

Effects of a new oral hypoglycaemic agent (CS-045) on metabolic abnormalities and insulin resistance in type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990068-0

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990068-0

Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990068-0

Effects of troglitazone: a new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990068-0

Suppression of hepatic gluconeogenesis in long-term Troglitazone treated diabetic KK and C57BL/KsJ-db/db mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990068-0

Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990068-0

Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990068-0

Bed-rest-induced insulin resistance occurs primarily in muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990068-0

Banting lecture 1988. Role of insulin resistance in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990068-0

10.1016/S0009-9236(97)90068-0

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9284856%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference